Details of the share-based compensation expense related to restricted stock units, stock grant awards and employee stock purchase plan is provided below:
|
Quarters Ended |
|
Six Months Ended |
|||||||||||||||||
|
July 3, 2020 |
|
April 3, 2020 |
|
June 28, 2019 |
|
July 3, 2020 |
|
June 28, 2019 |
|||||||||||
Cost of revenue |
$ |
2.8 |
|
|
$ |
2.5 |
|
|
$ |
3.5 |
|
|
$ |
5.3 |
|
|
$ |
5.4 |
|
|
Research and development |
4.4 |
|
|
4.1 |
|
|
5.4 |
|
|
8.5 |
|
|
9.0 |
|
||||||
Selling and marketing |
3.1 |
|
|
2.9 |
|
|
4.6 |
|
|
6.1 |
|
|
8.4 |
|
||||||
General and administrative |
7.7 |
|
|
6.2 |
|
|
13.8 |
|
|
13.8 |
|
|
24.2 |
|
||||||
Total share-based compensation expense |
$ |
18.0 |
|
|
$ |
15.7 |
|
|
$ |
27.3 |
|
|
$ |
33.7 |
|
|
$ |
47.0 |
|
|
NON-GAAP MEASURES
